Fat fat – but may strip your strength quietly

The loss of muscle (or skinny mass) is one of the common side effects of weight loss in adults with obesity and may negatively affect metabolism and bone health. This is because the muscles help in controlling blood sugar after meals and play an important role in maintaining the strength of the bone, according to the main researcher in the study, Melanie Henz, MD, from Massachusetts General Hospital and Harvard Medical College in Boston, Massachusetts.

Nearly 40 % of the lost weight of Smaglutide-a type of weight loss known as the GLP-1-comes from the meager mass, including muscles. Henz said it is not yet known to those who are at risk of muscle loss or how it affects blood sugar levels.

Researchers studied 40 obese adults for three months. Among these patients, 23 seconds of Smaglutide were prescribed, while 17 diets and lifestyle for weight loss are followed called HHL. The researchers assessed how muscle mass changes.

The study participants who were described for persistence in defending those who participated in the diet and lifestyle program, but the percentage of weight loss, which was a meager mass was similar between the two groups.

After calculating weight loss, the researchers found that in the semaglutide group, the elderly, females or protein were less than muscle loss. Also in this group, the loss of more muscles was associated with less sugar improvement (HBA1C levels).

“It may be likely to lose the elderly and women the muscles on the semules, but eating more protein may help protect from this,” Henns said. “The loss of many muscles may reduce the benefits of semuleside to control blood sugar. This means that maintaining muscles while losing weight with semiconduetide may be important to reduce insulin resistance and prevent weakness in people who are obese.”

Henz said that more studies are needed to find the best way to lose fat but keep the muscles when using GLP-1 medications.